Kadam Ss, S. Reddy, G Vidolkar, T. Kadam, Mumbai India Cytology Lab
{"title":"Unusual Presentation of a Renal Vein Invading Clear Cell Renal Cell Carcinoma with Non-Specific Gastrointestinal Symptomatology: A Case Report","authors":"Kadam Ss, S. Reddy, G Vidolkar, T. Kadam, Mumbai India Cytology Lab","doi":"10.26420/austinsurgoncol.2021.1019","DOIUrl":"https://doi.org/10.26420/austinsurgoncol.2021.1019","url":null,"abstract":"Introduction: We are reporting a case of 62 year old male patient with central obesity presented with nonspecific gastrointestinal symptoms which was misdiagnosed and treated according to its symptomology. After complete evaluation found to have a large right Renal Cell Carcinoma (RCC) with involvement of right renal vein and later he underwent right radical nephrectomy. The presentation of RCC is variable and most of the times it presents with nonspecific symptoms. The classic triad of loin pain, hematuria and abdominal mass is found only in 4-17 % of cases. The incidence of RCC is 2.2% and mortality rate is 1.8% worldwide, in 2018. In India, its incidence is around 1.3% and mortality is 1.3% in 2018. It occurs predominantly in the 6th to 8th decade of life with median age at diagnosis around 64 years. Due to earlier detection of these tumors, the incidence has increased threefold than the mortality. One of the established risk factor for RCC is cigarette smoking. As the use of cigarette smoking increases the stage of RCC advances further.","PeriodicalId":213899,"journal":{"name":"Austin Surgical Oncology","volume":"118 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121454807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Male Breast Cancer: Current Essentials & Review","authors":"Kadam Ss, T. Kadam","doi":"10.26420/austinsurgoncol.2021.1018","DOIUrl":"https://doi.org/10.26420/austinsurgoncol.2021.1018","url":null,"abstract":"Background: Breast cancer in male is a very rare condition but some of the reported case series had shown that its incidence is increasing over the last 25 years. The etiology of breast cancer in males differs from that of females in many ways. The literature lacks the prospective randomized evidences supporting the treatment of male breast cancer. Only retrospective evidences are available and all guidelines are extrapolated from the best available data of treatment of female breast cancer. Therefore, we have reviewed, compiled and tried to present the best available literature which highlights the treatment of male breast cancer .The reported incidence of breast cancer in men is around 1.2%-2% of all cancers in males and less than 1% of all breast cancers in both sexes. If it involves both breasts then it becomes an extremely uncommon condition which accounts for only 1% of all male breast cancer. Elderly males are most commonly diagnosed with breast cancer and they are approximately 5 to 10 years older than the women. The most common reason of breast cancer in males is excess of estrogen in the body and all conditions which leads to hyperestrogenism are responsible for increasing the risk of cancer.","PeriodicalId":213899,"journal":{"name":"Austin Surgical Oncology","volume":"423 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129337542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T. Yassein, H. Elghazaly, E. Ayoub, H. Omar, E. Elshiekh
{"title":"Locally Advanced of Periampullary Tumour...Is Curable?","authors":"T. Yassein, H. Elghazaly, E. Ayoub, H. Omar, E. Elshiekh","doi":"10.26420/austinsurgoncol/2020.1016","DOIUrl":"https://doi.org/10.26420/austinsurgoncol/2020.1016","url":null,"abstract":"Background: Pancreatic carcinoma is currently one of the deadliest of the solid malignancies and is the fourth cause of death from cancer in the United States, with a survival rate at 5 years of less than 5%. Most of cases diagnosed as advanced with vascular encasement or invasion and have chemotherapy for down staging to increase liability of resection with good results. Materials and Methods: 20 patients with diagnosis of locally advanced pancreatic carcinoma was examined and planned prospective to detect results of treatment and curability with prognosis in a period between start of January 2016 to end of December 2017. Conclusion: Pancreatic carcinoma may be curable with the use of MDT for treatment and neoadjuvant with surgery and vascular resection with follow up with CT, PET-CT and markers CA19.9 with good results and prognosis. Results: 20 patients included in this study, diagnosed as pancreatic head carcinoma in 10/20 (50%) and periampullary carcinoma in 10/20 (50%) of patients, all patients were diagnosed as locally advanced pancreatic cancer by radiological staging and diagnosis, 14/20 (70%) was males and 6/20 (30%) female, the age of patients at diagnosis was 39-62 years with median age 51 years.","PeriodicalId":213899,"journal":{"name":"Austin Surgical Oncology","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131670746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Impact of Depth of Invasion on Number of Cervical Lymph Nodes Infiltration in Cancer Lip","authors":"E. Essam, Salah T, Alghazaly A, I. M.","doi":"10.26420/austinsurgoncol/2020.1015","DOIUrl":"https://doi.org/10.26420/austinsurgoncol/2020.1015","url":null,"abstract":"Background: Lip cancer is a malignancy that results from the autonomous and uncontrolled cell growth in the lips. Lip cancer is a part of head and neck cancers and may occur together with oral cancer or may be one symptom of oral cancer. Lip cancers come in the form of squamous cell carcinoma with abnormal growth of the flat cells on the lips. Aim of the Work: To evaluate the relation and impact of the depth of invasion in mm of tumor to number of lymph nodes infiltrated. Material and Methods: 42 patients had lip cancer proved by biopsy or clinically to be malignant, undergone wide excision with safety margin with reconstruction either by primary repair or by loco regional flap with cervical nodes block dissection to evaluate the positive nodes number in relation to the depth of tumor. Results: Patients under went excision of lesion with lymph nodes with the increase in number of nodes infiltrated in proportion to the depth of invasion with increase recurrence rate irrespective to age of patients. Conclusion: Depth of tumor and number of lymph nodes infiltrated are important prognostic factors in lip cancer. be used as a predictor of neck metastasis in squamous cell carcinoma of the lower lip. This study was a retrospective analysis of the clinic pathologic factors related to Late Lymph Node Metastasis (LLNM) occurrence and to identify patients at risk, to improve neck management and prognostic outcomes in stage I and II SCC of the lip. cervical lymph node metastasis of oral squamous cell carcinoma of cN0; and further analysis found that the growth pattern, degree of differentiation, depth of invasion were all independent risk factors for cervical lymph node metastasis.","PeriodicalId":213899,"journal":{"name":"Austin Surgical Oncology","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133893888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Outcome of Breast Cancer after 10-15 Years Follow up","authors":"E. Elshiekh, A. ElGhazaly, T. Salah, M. Ibrahim","doi":"10.26420/austinsurgoncol/2019.1014","DOIUrl":"https://doi.org/10.26420/austinsurgoncol/2019.1014","url":null,"abstract":"Background: Breast cancer is the most common malignancy diagnosed in female, it was estimated that new cancer cases and cancer deaths were 1.3 million and 327,000 every year. Breast cancer is the most malignant type in females affecting 1 in every 8 female, it affect old age starting from above 50 years old but may affect also young age. Women undergone surgery or neoadjuvant treatment followed by surgery must be under follow up for a long time to detect any recurrence or metastases or even the development of 2 nd primary. Materials and Methods: Retrospective study done at Tanta cancer center and faculty medicine. Fayoum University between start of 2004-2009. Results: 170 patients collected between 2004-2009 with the age at diagnosis was 27-71 years and median age is 49 years old of patients, 90 was premenopausal while 80 was postmenopausal patients. All patients undergone follow up regularly according to schedule by routine visits. Local recurrence detected in 10 cases with liver metastases in 10 cases and pulmonary metastases in 10 cases with 41 patients died by end of 15 years mainly postmenopausal. Conclusion: The use of regular and closed follow up with definite schedule is of great value for detecting any progress development of local recurrence, distant recurrence or even the development of another primary.","PeriodicalId":213899,"journal":{"name":"Austin Surgical Oncology","volume":"52 5","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120915507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}